MEDICREA INTERNAT.
Identification
BRYAN GARNIER & CO
Operation
Global Placement and Open Price Offer
Conditions applying to both Global Placement and Open Price Offer (Ie notice for detail) The Global Placement Before first listing, a proportion of the shares will be included in a placement in France and an international private placement in some countries excluding the United States of America. - Underwriter: Bryan Garnier & Co Limited - Number of shares: 1 125 000 shares, that is 75% of the Offer Depending on the demand, the breakdown between the Placement and the OPO may be adapted as stated below. The Open Price Offer - Number of shares in the OPO: 375 000 shares, that is 25% of the Offer If the demand permits it, the number of shares offered within the OPO will be equal to 25% minimum of the Offer.
Admission on Alternext the 3 025 000 existing shares that comprise the equity of MEDICREA INTERNATIONAL at the day of the admission, a maximum of 2 357 223 new shares that will be issued in the admission framework.
1 500 000 shares will be offered to the public as part of a global placement and an open-price offer (OPO). The shares will be obtained from the issue of a capital increase permitted by the general meeting dated 10 March 2006 and to be realised with the listing and decided by the board of directors dated 9 May 2006.
Extension clause: (Ie notice for detail)
- Period of the Placement: from 14 to 23 June 2006 (12:00) - Period of the OPO: from 14 to 22 June 2006 (17h00) - First quotation: 23 June 2006 - Beginning of trading: 29 June 2006
BRYAN GARNIER & CO